Aptevo Therapeutics Announces Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
Company to Present New Data from On-Going Phase 1b Trial Evaluating Lead Candidate APVO436 for the Treatment of Acute Myeloid Leukemia
Title: "Updated Results from a Phase 1 Study of APVO436, a Novel Bispecific Anti-CD123 x Anti-CD3 ADAPTIR™ Molecule, in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome"
Date/Time:
Presenter:
About
CONTACT:
Email: IR@apvo.com or Millerm@apvo.com
Phone: 206-859-6628
SOURCE:
accesswire.com
https://www.accesswire.com/723685/Aptevo-Therapeutics-Announces-Poster-Presentation-at-the-64th-American-Society-of-Hematology-Annual-Meeting-and-Exposition